Quarterly Results

  • Company Name :
Gland Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543245
  • NSE Symbol:
  • GLAND
  • P/E(TTM):
  • 24.98
  • ISIN Demat:
  • INE068V01023
  • Div & Yield%:
  • 1.00
  • EPS(TTM):
  • 72.04
  • Book Value(₹):
  • 610.02
  • Market Cap(₹Cr.):
  • 29,646.27
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 1,177.51 1,074.15 1,038.84
Excise Duty 0.00 0.00 0.00
Net Sales 1,177.51 1,074.15 1,038.84
Other Operating Income 0.00 0.00 0.00
Other Income 60.21 82.59 54.74
Total Income 1,237.72 1,156.74 1,093.58
Total Expenditure 780.23 699.27 679.99
PBIDT 457.49 457.48 413.59
Interest 0.50 3.97 7.44
PBDT 456.99 453.51 406.15
Depreciation 44.53 44.84 43.77
Tax 110.21 105.90 93.27
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -5.60 0.78 -0.15
Reported Profit After Tax 307.85 302.00 269.26
Extra-ordinary Items -17.84 0.00 0.00
Adjusted Profit After Extra-ordinary item 325.69 302.00 269.26
EPS (Unit Curr.) 18.68 18.33 16.34
EPS (Adj) (Unit Curr.) 18.68 18.33 16.34
Calculated EPS (Unit Curr.) 18.68 18.33 16.34
Calculated EPS (Adj) (Unit Curr.) 18.68 18.33 16.34
Calculated EPS (Ann.) (Unit Curr.) 74.74 73.32 65.37
Calculated EPS (Adj) (Ann.) (Unit Curr.) 74.74 73.32 65.37
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 16.48 16.48 16.48
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 38.85 42.59 39.81
PBDTM(%) 38.81 42.22 39.10
PATM(%) 26.14 28.12 25.92